Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
Frontiers in Immunology
|
December 19, 2022
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines
Nouf Alluqmani, Anna Jirovec, Zaid Taha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model
Jean-Simon Diallo, Abdulhadi Aldejmah, Abdelali Filali Mouhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 30, 2013
Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia
David P Conrad, Jovian Tsang, Meaghan Maclean, et al.
Scientific Reports
|
November 16, 2024
High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activity
Boaz Wong, Rayanna Birtch, Anabel Bergeron, et al.
Breast Cancer Research : BCR
|
August 10, 2016
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
Marie-Claude Bourgeois-Daigneault, Lauren Elizabeth St-Germain, Dominic Guy Roy, et al.
Scientific Reports
|
January 7, 2026
Lipidomic profiling of influenza A virus production in MDCK cells towards targeted clone selection
Jocelyn A Menard, Tilia Zinnecker, Elena Godbout, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 9, 2013
HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy
Byram W Bridle, Lan Chen, Chantal G Lemay, et al.
Molecular Cancer Therapeutics
|
March 10, 2025
Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer
Alison O Cudmore, Galaxia M Rodriguez, Vincent Maranda, et al.
International Journal of Cancer
|
June 2, 2017
Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma
Fabrice Le Boeuf, Mohammed Selman, Hwan Hee Son, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 28, 2017
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds
Mohammed Selman, Christopher Rousso, Anabel Bergeron, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
Frontiers in Immunology
|
December 19, 2022
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines
Nouf Alluqmani, Anna Jirovec, Zaid Taha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model
Jean-Simon Diallo, Abdulhadi Aldejmah, Abdelali Filali Mouhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 30, 2013
Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia
David P Conrad, Jovian Tsang, Meaghan Maclean, et al.
Scientific Reports
|
November 16, 2024
High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activity
Boaz Wong, Rayanna Birtch, Anabel Bergeron, et al.
Breast Cancer Research : BCR
|
August 10, 2016
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
Marie-Claude Bourgeois-Daigneault, Lauren Elizabeth St-Germain, Dominic Guy Roy, et al.
Scientific Reports
|
January 7, 2026
Lipidomic profiling of influenza A virus production in MDCK cells towards targeted clone selection
Jocelyn A Menard, Tilia Zinnecker, Elena Godbout, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 9, 2013
HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy
Byram W Bridle, Lan Chen, Chantal G Lemay, et al.
Molecular Cancer Therapeutics
|
March 10, 2025
Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer
Alison O Cudmore, Galaxia M Rodriguez, Vincent Maranda, et al.
International Journal of Cancer
|
June 2, 2017
Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma
Fabrice Le Boeuf, Mohammed Selman, Hwan Hee Son, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 28, 2017
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds
Mohammed Selman, Christopher Rousso, Anabel Bergeron, et al.
Page
of 10